Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

Medical - Instruments & Supplies

Healthcare
$28.29 -0.37%

-$0.07 today

Market cap
$1.69B
Beta
0.83
P/E (TTM)
-6.9
EPS (TTM)
-$2.74
52W Low $13.25High $30.00

Volume 0.44M

Average 0.33M

KMTS Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Kestra Medical Technologies, Ltd.NASDAQ: KMTS

Net Change in Cash · Q3 FY2026 · quarter ended Jan 2026

Net change in cash turns positive

Q3 FY2026 net change in cash was $115.9M, compared with -$22.57M a year earlier. Trailing-twelve-month net change in cash was $236.97M.

Context

  • Net change in cash amounted to 383.4% of revenue in FY2025, up 359.2 pp from a year earlier.
  • Net change in cash increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly net change in cash holds near $115.9M or moves back toward the trailing-twelve-month quarterly average of $59.24M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJan 2026
$115.9M+549.4% QoQ
Last fiscal yearApr 2025
$229.35M+3503.3% YoY
LTMJan 2026
$236.97M+504.0% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+613.6%——
1 year+3503.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
229.35M USD
Year-over-year change
+3503.3%

Net Change in Cash vs competitors

How KMTS compares with its peers on the latest reported figures

  • KMTS's LTM Jan 2026 net change in cash of $236.97M is the largest of the 3 companies compared; the peer median is $59.37M.
  • Its year-over-year change of +504.0% is the highest of 3, against a peer median of -39.1%.
  • Net change in cash amounts to 283.0% of revenue for KMTS, versus a peer median of 34.4%.
KMTS Competitors Peer median
Net Change in Cash for KMTS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$236.97M +504.0%—283.0%
IRTCiRhythm Technologies, Inc.LTM Sep 2026$149.11M +156.5%+55.6%17.5%
CVRXCVRx, Inc.LTM Mar 2026$30.37M -234.6%-5.6%51.4%
Peer median (excluding KMTS) $59.37M-39.1%+25.0%34.4%

Competitors are the stored peer set for KMTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2020
Apr 2020
FY2021
Apr 2021
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Net Income(29.47M)(34.1M)(84.24M)(94.12M)(113.81M)
Depreciation & Amortization478K420K4.86M11.56M7.97M
Deferred Income Tax00(45K)12K64K
Stock-Based Compensation01.86M1.21M1.49M24.27M
Change in Working Capital(2.01M)(19K)1.3M4.39M(6.2M)
Accounts Receivables000(2M)(8.78M)
Inventory00(733K)(1.18M)(3.44M)
Accounts Payables(790K)(132K)2.14M7.34M2.84M
Other Working Capital(1.22M)113K(112K)223K3.18M
Other Non-Cash Items706K1.94M7.28M4.44M10.11M
Operating Cash Flow(30.29M)(29.9M)(69.64M)(72.24M)(77.61M)
Capital Expenditures(232K)(336K)(15.46M)(12.51M)(23.59M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities02K0285K283K
Investing Cash Flow(232K)(334K)(15.46M)(12.23M)(23.31M)
Debt Repayment020M(5.33M)5.88M0
Common Stock Issued0000215.79M
Common Stock Repurchased00000
Dividends Paid(183K)(187K)(671K)(799K)(1.65M)
Other Financing Activities30.42M29M0(2.35M)12.73M
Financing Cash Flow30.24M48.82M96.11M77.73M330.26M
Effect of Forex Changes00000
Net Change in Cash(286K)18.59M11M(6.74M)229.35M
Free Cash Flow(30.53M)(30.23M)(85.1M)(84.75M)(101.2M)

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

Intrinsic Alpha fair value

Locked

Current Price

$28.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.